Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Université D'Angers currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to a distinct examiner working within a distinct art unit. The concentration of the portfolio suggests a highly specialized or early-stage prosecution effort at the USPTO.
The busiest examiner for this portfolio is PALLAY, MICHAEL B, who is responsible for 1 pending office action. Because this examiner handles the entirety of the company's current pending workload, the prosecution strategy is currently dependent on the specific practices of this individual official. Practitioners should focus on the procedural preferences of this examiner to navigate the current pipeline effectively.
The presence of a single art unit indicates that the current intellectual property focus remains narrow. This alignment simplifies the administrative tracking of the portfolio. Future filings will determine if the company expands its footprint beyond this initial biotechnology focus. The current data reflects a focused interaction with the patent office where the active matter represents the total workload.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PALLAY, MICHAEL B | 1 | 55.8% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18714804 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | PALLAY, MICHAEL B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18714804 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | PALLAY, MICHAEL B | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18714804 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | PALLAY, MICHAEL B | 1617 | §103§112 | Non-Final OA | — | Pending | May 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversité D'Angers has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Michael B Pallay has the most, with 1 of Université D'Angers's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
